A detailed history of Black Rock Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,644,711 shares of ADMA stock, worth $316 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,644,711
Previous 18,199,277 2.45%
Holding current value
$316 Million
Previous $120 Million 73.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $2.66 Million - $4.98 Million
445,434 Added 2.45%
18,644,711 $208 Million
Q1 2024

May 10, 2024

BUY
$4.4 - $6.74 $1.24 Million - $1.9 Million
281,532 Added 1.57%
18,199,277 $120 Million
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $3.88 Million - $5.69 Million
1,259,538 Added 7.56%
17,917,745 $81 Million
Q3 2023

Nov 13, 2023

BUY
$3.47 - $4.61 $1.02 Million - $1.35 Million
293,085 Added 1.79%
16,658,207 $59.6 Million
Q2 2023

Aug 11, 2023

SELL
$3.12 - $4.22 $81,734 - $110,551
-26,197 Reduced 0.16%
16,365,122 $60.4 Million
Q1 2023

May 12, 2023

BUY
$3.01 - $3.87 $3.88 Million - $4.99 Million
1,290,038 Added 8.54%
16,391,319 $54.3 Million
Q4 2022

Feb 13, 2023

BUY
$2.47 - $3.88 $5.25 Million - $8.25 Million
2,125,687 Added 16.38%
15,101,281 $58.6 Million
Q3 2022

Nov 14, 2022

BUY
$2.03 - $2.86 $781,282 - $1.1 Million
384,868 Added 3.06%
12,975,594 $31.5 Million
Q2 2022

Aug 12, 2022

BUY
$1.43 - $2.2 $12.1 Million - $18.7 Million
8,483,344 Added 206.54%
12,590,726 $24.9 Million
Q1 2022

May 12, 2022

BUY
$1.28 - $1.83 $40,692 - $58,177
31,791 Added 0.78%
4,107,382 $7.52 Million
Q4 2021

Feb 10, 2022

BUY
$1.09 - $1.66 $1.88 Million - $2.86 Million
1,724,224 Added 73.33%
4,075,591 $5.75 Million
Q3 2021

Nov 09, 2021

BUY
$1.13 - $1.65 $195,642 - $285,672
173,135 Added 7.95%
2,351,367 $2.66 Million
Q2 2021

Aug 11, 2021

BUY
$1.51 - $2.07 $3.29 Million - $4.51 Million
2,178,232 New
2,178,232 $3.48 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.33B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.